Crossmark

Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2022.05.012

Published Print: 2023-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sanz-Garcia, Carlos

Nevzorova, Yulia A.

Martínez-Naves, Eduardo

Cubero, Francisco Javier

Hionides-Gutierrez, Alejandro

Sañudo, Jose Ramón

Enrich, Carlos

Rentero, Carles

Sancho-Bru, Pau

Macías-Rodriguez, Ricardo U.

Ruiz-Margain, Astrid

Kershenobich-Stalnikowitz, David

Vargas, Nestor R.

Muñoz, Alberto E.

Nakaya, Helder I.
License Information

Text and Data Mining valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01

stm-asf valid from 2023-04-01
More Information

This article is maintained by: Elsevier

Article Title: Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2022.05.012

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below